Yip TCF - Search Results

1

Temporal matrix completion with locally linear latent factors for medical applications.

Ma AJ, Chan JCP, Chan FKS, Yuen PC, Yip TCF, Tse YK, Wong VWS, Wong GLH. Ma AJ, et al. Among authors: yip tcf. Artif Intell Med. 2020 Jul;107:101883. doi: 10.1016/j.artmed.2020.101883. Epub 2020 Jun 1. Artif Intell Med. 2020. PMID: 32828441

2

Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma.

Wong GL, Tse YK, Chan HL, Yip TC, Tsoi KK, Wong VW. Wong GL, et al. Aliment Pharmacol Ther. 2016 Apr;43(7):802-13. doi: 10.1111/apt.13548. Epub 2016 Feb 4. Aliment Pharmacol Ther. 2016. PMID: 26843444 Free article.

3

Long-term use of oral nucleos(t)ide analogues for chronic hepatitis B does not increase cancer risk - a cohort study of 44 494 subjects.

Wong GL, Tse YK, Yip TC, Chan HL, Tsoi KK, Wong VW. Wong GL, et al. Aliment Pharmacol Ther. 2017 May;45(9):1213-1224. doi: 10.1111/apt.14015. Epub 2017 Feb 27. Aliment Pharmacol Ther. 2017. PMID: 28239880

4

Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.

Yip TC, Ma AJ, Wong VW, Tse YK, Chan HL, Yuen PC, Wong GL. Yip TC, et al. Aliment Pharmacol Ther. 2017 Aug;46(4):447-456. doi: 10.1111/apt.14172. Epub 2017 Jun 6. Aliment Pharmacol Ther. 2017. PMID: 28585725 Clinical Trial.

5

Editorial: progress towards a simple tool for screening for hepatic steatosis in the general population - authors' reply.

Yip TC, Ma AJ, Yuen PC, Wong GL. Yip TC, et al. Aliment Pharmacol Ther. 2017 Sep;46(5):560-561. doi: 10.1111/apt.14234. Aliment Pharmacol Ther. 2017. PMID: 28776735 No abstract available.

6

Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis.

Wong JC, Chan HL, Tse YK, Yip TC, Wong VW, Wong GL. Wong JC, et al. Aliment Pharmacol Ther. 2017 Nov;46(10):1001-1010. doi: 10.1111/apt.14341. Epub 2017 Sep 21. Aliment Pharmacol Ther. 2017. PMID: 28940673

7

Development and validation of a model for hepatitis B e antigen seroconversion in entecavir-treated patients with chronic hepatitis B.

Shen S, Wong GL, Kuang Z, van Campenhout MJH, Fan R, Wong VW, Yip TC, Chi H, Liang X, Hu X, Lin W, Wu Y, Liu X, Boonstra A, Hou J, Sun J, Chan HL. Shen S, et al. J Med Virol. 2020 Aug;92(8):1206-1213. doi: 10.1002/jmv.25628. Epub 2019 Nov 21. J Med Virol. 2020. PMID: 31724212

8

The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B.

Wong GL, Chan HL, Yuen BW, Tse YK, Luk HW, Yip TC, Hui VW, Liang LY, Lee HW, Lui GC, Wong VW. Wong GL, et al. Liver Int. 2020 Mar;40(3):549-557. doi: 10.1111/liv.14330. Epub 2019 Dec 30. Liver Int. 2020. PMID: 31845462

9

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply.

Yip TC, Wong GL. Yip TC, et al. Aliment Pharmacol Ther. 2020 Jan;51(2):315-316. doi: 10.1111/apt.15614. Aliment Pharmacol Ther. 2020. PMID: 31880016 No abstract available.

10

Collateral Effect of Coronavirus Disease 2019 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases: A Territory-wide Observational Study in Hong Kong.

Lau LHS, Wong SH, Yip TCF, Wong GLH, Wong VWS, Sung JJY. Lau LHS, et al. Among authors: yip tcf. Gastroenterology. 2020 Nov;159(5):1979-1981.e3. doi: 10.1053/j.gastro.2020.07.042. Epub 2020 Jul 25. Gastroenterology. 2020. PMID: 32721440 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page